Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
898 Ergebnisse
| GW1J0G | Regeneron Pharmaceuticals Inc./OS/Call [780]/GOLDS | - | - | 780,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,966 % | 0,514 | -0,009 | 3,340 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1J0M | Regeneron Pharmaceuticals Inc./OS/Call [780]/GOLDS | - | - | 780,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,670 % | 0,484 | -0,009 | 3,454 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K3T | Regeneron Pharmaceuticals Inc./OS/Call [780]/GOLDS | - | - | 780,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,826 % | 0,420 | -0,010 | 4,438 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW1K47 | Regeneron Pharmaceuticals Inc./OS/Call [780]/GOLDS | - | - | 780,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,990 % | 0,451 | -0,009 | 3,893 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW1K7U | Regeneron Pharmaceuticals Inc./OS/Call [780]/GOLDS | - | - | 780,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,131 % | 0,494 | -0,009 | 3,311 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW3SBW | Regeneron Pharmaceuticals Inc./OS/Call [780]/GOLDS | - | - | 780,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,131 % | 0,511 | -0,008 | 3,144 | 17.03.2028 | 0,010 | Goldman Sachs | ||
| GW4QF5 | Regeneron Pharmaceuticals Inc./OS/Call [780]/GOLDS | - | - | 780,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,268 % | 0,529 | -0,008 | 2,931 | 16.06.2028 | 0,010 | Goldman Sachs | ||
| JZ6QM1 | Regeneron Pharmaceuticals Inc./OS/Call [780]/JPMD | - | - | 780,000 | call | Regeneron Pharmaceuticals Inc. | - | 35,747 % | 0,309 | -0,011 | 7,096 | 15.01.2027 | 0,010 | JP Morgan | ||
| JE1Y9N | Regeneron Pharmaceuticals Inc./OS/Call [780]/JPMD | - | - | 780,000 | call | Regeneron Pharmaceuticals Inc. | - | 35,930 % | 0,328 | -0,013 | 7,450 | 18.12.2026 | 0,010 | JP Morgan | ||
| JE0H8M | Regeneron Pharmaceuticals Inc./OS/Call [780]/JPMD | - | - | 780,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,375 % | 0,366 | -0,011 | 5,509 | 19.03.2027 | 0,010 | JP Morgan | ||
| GW0VHW | Regeneron Pharmaceuticals Inc./OS/Call [790]/GOLDS | - | - | 790,000 | call | Regeneron Pharmaceuticals Inc. | - | 32,608 % | 0,311 | -0,011 | 7,663 | 15.01.2027 | 0,010 | Goldman Sachs | ||
| GW0VHT | Regeneron Pharmaceuticals Inc./OS/Call [790]/GOLDS | - | - | 790,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,342 % | 0,406 | -0,010 | 4,545 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW0VJ0 | Regeneron Pharmaceuticals Inc./OS/Call [790]/GOLDS | - | - | 790,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,581 % | 0,389 | -0,011 | 5,475 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW1J0A | Regeneron Pharmaceuticals Inc./OS/Call [790]/GOLDS | - | - | 790,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,419 % | 0,501 | -0,009 | 3,412 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1J0N | Regeneron Pharmaceuticals Inc./OS/Call [790]/GOLDS | - | - | 790,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,474 % | 0,472 | -0,009 | 3,504 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K48 | Regeneron Pharmaceuticals Inc./OS/Call [790]/GOLDS | - | - | 790,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,840 % | 0,441 | -0,009 | 3,940 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW1K4U | Regeneron Pharmaceuticals Inc./OS/Call [790]/GOLDS | - | - | 790,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,565 % | 0,511 | -0,009 | 3,290 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1K8R | Regeneron Pharmaceuticals Inc./OS/Call [790]/GOLDS | - | - | 790,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,835 % | 0,409 | -0,010 | 4,487 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW3S5R | Regeneron Pharmaceuticals Inc./OS/Call [790]/GOLDS | - | - | 790,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,231 % | 0,500 | -0,008 | 3,170 | 17.03.2028 | 0,010 | Goldman Sachs | ||
| GW4QF7 | Regeneron Pharmaceuticals Inc./OS/Call [790]/GOLDS | - | - | 790,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,158 % | 0,543 | -0,008 | 2,897 | 16.06.2028 | 0,010 | Goldman Sachs | ||
| PL1GHC |  | Regeneron Pharmaceuticals Inc./OS/Call [800]/BNP | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,725 % | 0,268 | -0,012 | 7,296 | 18.12.2026 | 0,010 | BNP Paribas | |
| PL1LRU | | Regeneron Pharmaceuticals Inc./OS/Call [800]/BNP | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,448 % | 0,287 | -0,011 | 6,820 | 15.01.2027 | 0,010 | BNP Paribas | |
| PL69PG | | Regeneron Pharmaceuticals Inc./OS/Call [800]/BNP | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 47,938 % | 0,170 | -0,017 | 10,658 | 18.09.2026 | 0,010 | BNP Paribas | |
| PJ912M | | Regeneron Pharmaceuticals Inc./OS/Call [800]/BNP | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,014 % | 0,341 | -0,011 | 5,574 | 19.03.2027 | 0,010 | BNP Paribas | |
| PK0116 | | Regeneron Pharmaceuticals Inc./OS/Call [800]/BNP | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,197 % | 0,504 | -0,009 | 3,241 | 17.12.2027 | 0,010 | BNP Paribas | |
| PK9XE7 | | Regeneron Pharmaceuticals Inc./OS/Call [800]/BNP | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,526 % | 0,487 | -0,009 | 3,194 | 21.01.2028 | 0,010 | BNP Paribas | |
| PK927Z | | Regeneron Pharmaceuticals Inc./OS/Call [800]/BNP | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 44,096 % | 0,530 | -0,009 | 2,936 | 17.03.2028 | 0,010 | BNP Paribas | |
| PK95YZ | | Regeneron Pharmaceuticals Inc./OS/Call [800]/BNP | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 45,086 % | 0,530 | -0,008 | 2,752 | 16.06.2028 | 0,010 | BNP Paribas | |
| PM03WZ | | Regeneron Pharmaceuticals Inc./OS/Call [800]/BNP | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,693 % | 0,399 | -0,010 | 4,453 | 17.06.2027 | 0,010 | BNP Paribas | |
| PM5036 | | Regeneron Pharmaceuticals Inc./OS/Call [800]/BNP | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,061 % | 0,442 | -0,010 | 3,773 | 17.09.2027 | 0,010 | BNP Paribas | |
| GJ91XQ | Regeneron Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 33,612 % | 0,220 | -0,009 | 8,971 | 18.12.2026 | 0,010 | Goldman Sachs | ||
| GV70MT | Regeneron Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,382 % | 0,124 | -0,012 | 13,415 | 18.09.2026 | 0,010 | Goldman Sachs | ||
| GU3T40 | Regeneron Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,946 % | 0,332 | -0,013 | 6,555 | 15.01.2027 | 0,010 | Goldman Sachs | ||
| GW01CT | Regeneron Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,884 % | 0,502 | -0,009 | 3,299 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW02S6 | Regeneron Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,809 % | 0,374 | -0,011 | 5,528 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW02S0 | Regeneron Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,566 % | 0,460 | -0,010 | 3,889 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW02RZ | Regeneron Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,525 % | 0,428 | -0,011 | 4,428 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW05ZV | Regeneron Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,474 % | 0,501 | -0,009 | 3,329 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1J0L | Regeneron Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,647 % | 0,492 | -0,009 | 3,428 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K5D | Regeneron Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,784 % | 0,475 | -0,008 | 3,391 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1K71 | Regeneron Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,045 % | 0,430 | -0,009 | 3,965 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW1K70 | Regeneron Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,647 % | 0,492 | -0,009 | 3,428 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K8H | Regeneron Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,871 % | 0,397 | -0,010 | 4,535 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW3SBK | Regeneron Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,930 % | 0,489 | -0,008 | 3,216 | 17.03.2028 | 0,010 | Goldman Sachs | ||
| GW4QFE | Regeneron Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,605 % | 0,513 | -0,008 | 2,957 | 16.06.2028 | 0,010 | Goldman Sachs | ||
| GW5EBV | Regeneron Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 50,785 % | 0,145 | -0,022 | 14,038 | 21.08.2026 | 0,010 | Goldman Sachs | ||
| GW85E3 | Regeneron Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,397 % | 0,281 | -0,014 | 7,918 | 20.11.2026 | 0,010 | Goldman Sachs | ||
| GW9AGM | Regeneron Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | 1.000,000 | 35,958 % | - | - | - | 19.03.2027 | 0,100 | Goldman Sachs | ||
| GW9AGY | Regeneron Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | 1.000,000 | 33,596 % | - | - | - | 18.12.2026 | 0,100 | Goldman Sachs | ||
| GW9AJR | Regeneron Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | 900,000 | 40,515 % | - | - | - | 19.03.2027 | 0,100 | Goldman Sachs |